bluebird bio (BLUE) AML Case is Unlikely Driven By Lentiglobin, Here's Why - Morgan Stanley
Go back to bluebird bio (BLUE) AML Case is Unlikely Driven By Lentiglobin, Here's Why - Morgan Stanley| BLUEBIRD BIO (NASDAQ: BLUE) | Delayed: 1.02 +0.07 (7.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $95.28 | |||
| Open | $0.95 | 52 Week Low | $35.37 | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $-1.81 | |||
| Volume | 8,178,365 | |||||
